Notably, a biomarker panel containing lactoferrin (LTF) and the bacterial phosphopyruvate hydratase (ppdK, K01006) - a core glycolytic enzyme - achieved enhanced discrimination of both ulcerative colitis (UC) and Crohn’s disease (CD). This evidence concerns the gene ENO1 and ulcerative colitis.